861840-51-9

Basic information

• Product Name: Benzoic acid, 2-(broMoMethyl)-6-iodo-, Methyl ester
• Synonyms: Benzoic acid, 2-(broMoMethyl)-6-iodo-, Methyl ester
• CAS NO: 861840-51-9
• Molecular Formula: C₉H₈BrIO₂
• Molecular Weight: 354.96709
• Mol File: 861840-51-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzoic acid, 2-(broMoMethyl)-6-iodo-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-(broMoMethyl)-6-iodo-, Methyl ester(861840-51-9)
• EPA Substance Registry System: Benzoic acid, 2-(broMoMethyl)-6-iodo-, Methyl ester(861840-51-9)

Safety Data

• Hazardous Substances Data: 861840-51-9(Hazardous Substances Data)

Upstream product

• 103440-55-7 2-methyl-6-iodobenzoic acid methyl ester 
• 54811-50-6 2-iodo-6-methylbenzoic acid 
• 52107-92-3 2-iodo-6-methylbenzoyl chloride 
• 118-90-1 ortho-methylbenzoic acid 

Relevant articles and documents

EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE

The present disclosure relates to bifunctional compounds, which find utility as modulators of receptor tyrosine kinase (RTK) proteins. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand which binds to an E3 ubiquitin ligase and on the other end a moiety which binds a target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effectuate ubiquitination, and therefore, degradation (and inhibition) of the target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Synthesis of 2-substituted β-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon

β-Cyclodextrin was substituted by an iodosobenzoic acid derivative to create a catalytic hydrolytic activity against neurotoxic organophosphorus agents. The catalytic moiety was introduced on a secondary hydroxy group at the position 2 of a glucose unit.